Maria de Miguel, MD
Internal Medicine · New York, NYNPI 1699935999
Payments from drug & device makers
What this record shows
That places this record below the midpoint for internal medicine clinicians in NY, where the typical reported total is $194.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 14 payments — averaging $30,599 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biontech SE$418K
- Alkermes, Inc.$10K
How this compares
$0 in reported general payments places this provider in the 15th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 247 | $255,596 |
| OzempicSemaglutide | 142 | $134,573 |
| JanuviaSitagliptin Phosphate | 72 | $64,606 |
| EntrestoSacubitril/Valsartan | 38 | $40,323 |
| RybelsusSemaglutide | 26 | $35,347 |
| EliquisApixaban | 40 | $35,342 |
| XareltoRivaroxaban | 37 | $32,185 |
| TradjentaLinagliptin | 25 | $30,700 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 46 | $28,581 |
| LinzessLinaclotide | 37 | $25,672 |
| TrulicityDulaglutide | 25 | $22,875 |
| FarxigaDapagliflozin Propanediol | 17 | $21,837 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 17 | $20,793 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 31 | $19,776 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 14 | $8,670 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New York
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
- Terry PlasseNew York$883K
- Krisczar BungayNew York$554K
- Eytan SteinNew York$496K
- Larry NeumanNew York$457K
- Wuhua JingNew York$338K
- Harvey SchneienNew York$334K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.